Avid Bioservices Inc (CDMO)

[seamoss58]

Wow, I see 8...

Did I miss any?

cmos




http://www.aacr.org/home/scientists/meetings--workshops/annual-meeting-2007.aspx


Abstract Number: 4095
Presentation Title: Selective targeting of cellular immune responses by
chimeric and humanized monoclonal antibodies to phosphatidylserine exposed
in tumor vasculature
Presentation Start/End Time: Tuesday, Apr 17, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 32
Poster Board Number: 10
Author Block: Monica Friedrich, Amy Brideau-Andersen, Bruce Freimark,
Connie Chang. Peregrine Pharmaceuticals, Inc., Tustin, CA

Abstract Number: 2128
Presentation Title: Blockade of tumor-derived VEGF activation of VEGF receptor 2
reduces macrophage infiltration into tumors and decreases metastasis in a
pre-clinical orthotopic model of pancreatic cancer
Presentation Start/End Time: Monday, Apr 16, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 20
Poster Board Number: 11
Author Block: Juliet G. Carbon, Shane E. Holloway, Andrew F. Miller,
Anita Kavlie, Kyle Schlunegger, Jason B. Fleming, Rolf A. Brekken. UT Southwestern
Medical Ctr., Dallas, TX, Affitech AS, Oslo, Norway,
Peregrine Pharmaceuticals Inc, Tustin, CA, UT-MD Anderson, Houston, TX


Abstract Number: 4091
Presentation Title: Enhancing the immunogenicity of glioma cells with
anti-phosphatidylserine antibody.
Presentation Start/End Time: Tuesday, Apr 17, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 32
Poster Board Number: 6
Author Block: Jin He, Troy A. Luster, Philip E. Thorpe. UT Southwestern
Medical Ctr., Dallas, TX


Abstract Number: 4092
Presentation Title: Targeting truncated tissue factor with tumor vasculature
specific monoclonal antibodies: developing coaguligands as cancer therapeutics
Presentation Start/End Time: Tuesday, Apr 17, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 32
Poster Board Number: 7
Author Block: Richard H. Archer, Mary Wakabayashi, Roy Sevilla, Scott Summers,
Steven King, Ronald T. Aimes. Peregrine Pharmaceuticals, Inc., Tustin, CA


Abstract Number: 4190
Presentation Title: Vasopermeation enhancement agents: A case study in screening
for the most potent variant in a new class of compounds by using a novel avian
embryonic system
Presentation Start/End Time: Tuesday, Apr 17, 2007, 12:10 PM -12:25 PM
Location: Room 515 A, Los Angeles Convention Center
Author Block: Kelly A. Felton, John D. Lewis, Andries Zijlstra, Jennifer Chase,
Keith A. Luhrs, Aparna I. Roy, Debra A. Harris, Christian Frosch, Steven W. King,
Missag H. Parseghian. Peregrine Pharmaceuticals, Tustin, CA, London Regional
Cancer Program, London, ON, Canada, Vanderbilt University, Nashville, TN,
Innovascreen, Halifax, NS, Canada, Biobroker, Hamburg, Germany


Abstract Number: 4089
Presentation Title: Fusion proteins composed of mouse IgG2a Fc and mouse
beta-2-glycoprotein 1 bind to endothelial cells with exposed phosphatidylserine
Presentation Start/End Time: Tuesday, Apr 17, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 32
Poster Board Number: 4
Author Block: Troy A. Luster, Philip E. Thorpe. Unversity of Texas Southwestern
Medical Center, Dallas, TX


Abstract Number: 3273
Presentation Title: Vascular targeting antibody improves chemotherapy of prostate
cancer
Presentation Start/End Time: Monday, Apr 16, 2007, 1:00 PM - 5:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 30
Poster Board Number: 5
Author Block: Yi Yin, Xianming Huang, Jin He, Troy A. Luster, Philip E. Thorpe.
UT Southwestern Medical Center, Dallas, TX


Abstract Number: 3539
Presentation Title: Inhibition of tumor growth by targeting cytokines to the
inside-out phosphatidylserine (PS) on tumor vascular endothelium with 2aG4
Presentation Start/End Time: Tuesday, Apr 17, 2007, 8:00 AM -12:00 PM
Location: Exhibit Hall, Los Angeles Convention Center
Poster Section: 8
Poster Board Number: 3
Author Block: Xianming Huang, Dan Ye, Philip Thorpe. UT Southwestern Medical Ctr.,
Dallas, TX